Are DNA Repair Factors Promising Biomarkers for Personalized Therapy in Gastric Cancer?
Tarek M.A. Abdel-Fatah(University of Nottingham), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Ipek Gorguc(Nottingham University Hospitals NHS Trust), Claire Hawkes(University of Warwick), Arvind Arora(Himalayan Institute Hospital Trust), Rachel Abbotts(University of Nottingham), Sarah Beebeejaun(Nottingham University Hospitals NHS Trust), Vivek Mohan(University of Nottingham), Irshad Soomro, Dileep N. Lobo(Nottingham University Hospitals NHS Trust), Simon L. Parsons(Galapagos (Belgium)), Sarah J. Storr(Nottingham University Hospitals NHS Trust)
Cited by 24
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
The Attractive Female Body Weight and Female Body Dissatisfaction in 26 Countries Across 10 World Regions: Results of the International Body Project I
|Personality and Social Psychology Bulletin|2010|718
Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations
|World Journal of Surgery|2016|607